ArticleInfectious diseases and therapy2024

Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan.

Shohei Shinozaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.